Eli Lilly | LLY - Assets

Stock Price
1,003.46
Daily Change
-40.67 -3.90%
Monthly
-3.65%
Yearly
21.47%
Q1 Forecast
1,005.21

Eli Lilly reported $114.94B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Abbott USD 84.18B 182M Sep/2025
ALKERMES USD 2.33B 76.7M Sep/2025
Amgen USD 90.14B 2.24B Sep/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Baxter International USD 21.07B 21M Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Drreddys Laboratories INR 6.26B 161.9M Dec/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.34B 2.08B Sep/2025
Glaxosmithkline GBP 82.45B 23.19B Sep/2025
J&J USD 192.82B 573M Sep/2025
Medtronic USD 90.97B 708M Jun/2025
Merck USD 129.55B 12.02B Sep/2025
Neurocrine Biosciences USD 4.27B 375.9M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novo Nordisk DKK 512.29B 30.14B Sep/2025
Perrigo USD 10.08B 10.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Prestige Brands USD 3.44B 10.66M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sanofi EUR 126.81B 25.48B Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
Zoetis USD 15.16B 680M Sep/2025